PLENAXIS

Serial Number 75319050
606

Registration Progress

Application Filed
Jul 3, 1997
Under Examination
Jun 30, 1998
Approved for Publication
Mar 7, 1998
Published for Opposition
Apr 7, 1998
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: PLENAXIS
Previous Owner: Amgen Inc.
Classes: 005

Trademark Image

PLENAXIS

Basic Information

Serial Number
75319050
Filing Date
July 3, 1997
Published for Opposition
April 7, 1998
Abandonment Date
July 1, 2001
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 1, 2001
Classes
005

Rights Holder

Amgen Inc.

03
Address
1840 DeHavilland Drive
Thousand Oaks, CA 913201789

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Amgen Inc.

Owner at Publication
03
Thousand Oaks, CA

Legal Representation

Attorney
MARK I FELDMAN

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

17 events
Date Code Type Description Documents
Aug 26, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 19, 2000 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 19, 2000 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 21, 2000 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 29, 2000 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 18, 1999 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 19, 1999 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 14, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 14, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 28, 1998 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 3, 1998 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 30, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 7, 1998 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 7, 1998 NPUB O NOTICE OF PUBLICATION Loading...
Feb 4, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 4, 1998 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 3, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
prescription pharmaceuticals for treatment of neurological disorders, for promoting growth and differentiation of neurons and for preventing neuronal death
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005